North America Orthopedic Regenerative Surgical Products Market Size, Share & Industry Trends Analysis Report By End-Use (Hospitals, Ambulatory Surgical Centers and Others), By Application, By Product, By Country and Growth Forecast, 2023

List of Tables

The North America Orthopedic Regenerative Surgical Products Market would witness market growth of 3.7% CAGR during the forecast period (2023-2030).

The workings of crucial pathways for regeneration and healing have been dramatically unveiled by fundamental advancements in basic research. Various primary and supplementary regeneration therapies are becoming more accessible, including preparations generated from bone marrow, growth hormones, and stem cells. Clinical practice is being transformed by supporting therapies that are efficient both during the index surgery and the postoperative period in the latest phase of biologically active material application. Regenerative therapies are now being improved in many facets of orthopedic surgery to improve success and outcomes.

Regenerative orthopedics can lessen discomfort and pain in the musculoskeletal structures and speed up the recovery from orthopedic disorders like injuries to the tendons, ligaments, bones, muscles, and meniscus. As these are unable to repair themselves, these tissues can mend more quickly because of regenerative therapy. Certain degenerative disorders, such as arthritis and sports injuries, can be treated using regenerative orthopedics or orthobiologics. Regenerative medicine may enable some patients to postpone their requirement for orthopedic surgery.

When used to treat early stages of arthritis, such as early knee osteoarthritis, or tendinopathies like tennis elbow (lateral epicondylitis), biologic therapy has shown promise and may help postpone surgery. These can also help the body mend following surgery to repair particular tendons, such as the rotator cuff, and address avascular necrosis (death of bone tissue brought on by a short- or long-term absence of blood supply to the bone).

In the United States, an estimated 58.5 million persons have arthritis, which is much more common in women than men, according to statistics from the Centers for Disease Control and Prevention (CDC) from 2023. Additionally, 78.4 million, or about 25.9% of the estimated adult population, persons aged 18 and older will have arthritis officially diagnosed by a doctor by 2040, according to the CDC. Furthermore, North America's market has experienced tremendous growth due to the high awareness of these products and the high prevalence of arthritis joint pain among adults in the United States, along with other co-occurring conditions like diabetes. Hence, the region presents lucrative growth prospects for the market.

The US market dominated the North America Orthopedic Regenerative Surgical Products Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,534.2 million by 2030. The Canada market is experiencing a CAGR of 6.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.1% during (2023 - 2030).

Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Application, the market is segmented into Joint Reconstruction, Cartilage & Tendon Repair, Trauma Repair, Orthopedic Pain Management and Others. Based on Product, the market is segmented into Viscosupplements, Allografts (Amniotic Products and Others), Synthetic and Cell-based. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Vericel Corporation, Baxter International, Inc., Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew, Arthrex, Inc., BioTissue Holdings, Inc., VSY Biotechnology GmbH and Aptissen S.A.

Scope of the Study

Market Segments covered in the Report:

By End-use

Hospitals
Ambulatory Surgical Centers
Others

By Application

Joint Reconstruction
Cartilage & Tendon Repair
Trauma Repair
Orthopedic Pain Management
Others

By Product

Viscosupplements
Allografts
- Amniotic Products
- Others
Synthetic
Cell-based

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

MiMedx Group, Inc.
Vericel Corporation
Baxter International, Inc.
Zimmer Biomet Holdings, Inc.
Stryker Corporation
Smith & Nephew
Arthrex, Inc.
BioTissue Holdings, Inc.
VSY Biotechnology GmbH
Aptissen S.A.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Orthopedic Regenerative Surgical Products Market, by End-use
- 1.4.2 North America Orthopedic Regenerative Surgical Products Market, by Application
- 1.4.3 North America Orthopedic Regenerative Surgical Products Market, by Product
- 1.4.4 North America Orthopedic Regenerative Surgical Products Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. North America Orthopedic Regenerative Surgical Products Market by End-use

4.1 North America Hospitals Market by Country
4.2 North America Ambulatory Surgical Centers Market by Country
4.3 North America Others Market by Country

Chapter 5. North America Orthopedic Regenerative Surgical Products Market by Application

5.1 North America Joint Reconstruction Market by Country
5.2 North America Cartilage & Tendon Repair Market by Country
5.3 North America Trauma Repair Market by Country
5.4 North America Orthopedic Pain Management Market by Country
5.5 North America Others Market by Country

Chapter 6. North America Orthopedic Regenerative Surgical Products Market by Product

6.1 North America Viscosupplements Market by Country
6.2 North America Allografts Market by Country
6.3 North America Orthopedic Regenerative Surgical Products Market by Allografts Type
- 6.3.1 North America Amniotic Products Market by Country
- 6.3.2 North America Others Market by Country
6.4 North America Synthetic Market by Country
6.5 North America Cell-based Market by Country

Chapter 7. North America Orthopedic Regenerative Surgical Products Market by Country

7.1 US Orthopedic Regenerative Surgical Products Market
- 7.1.1 US Orthopedic Regenerative Surgical Products Market by End-use
- 7.1.2 US Orthopedic Regenerative Surgical Products Market by Application
- 7.1.3 US Orthopedic Regenerative Surgical Products Market by Product
  - 7.1.3.1 US Orthopedic Regenerative Surgical Products Market by Allografts Type
7.2 Canada Orthopedic Regenerative Surgical Products Market
- 7.2.1 Canada Orthopedic Regenerative Surgical Products Market by End-use
- 7.2.2 Canada Orthopedic Regenerative Surgical Products Market by Application
- 7.2.3 Canada Orthopedic Regenerative Surgical Products Market by Product
  - 7.2.3.1 Canada Orthopedic Regenerative Surgical Products Market by Allografts Type
7.3 Mexico Orthopedic Regenerative Surgical Products Market
- 7.3.1 Mexico Orthopedic Regenerative Surgical Products Market by End-use
- 7.3.2 Mexico Orthopedic Regenerative Surgical Products Market by Application
- 7.3.3 Mexico Orthopedic Regenerative Surgical Products Market by Product
  - 7.3.3.1 Mexico Orthopedic Regenerative Surgical Products Market by Allografts Type
7.4 Rest of North America Orthopedic Regenerative Surgical Products Market
- 7.4.1 Rest of North America Orthopedic Regenerative Surgical Products Market by End-use
- 7.4.2 Rest of North America Orthopedic Regenerative Surgical Products Market by Application
- 7.4.3 Rest of North America Orthopedic Regenerative Surgical Products Market by Product
  - 7.4.3.1 Rest of North America Orthopedic Regenerative Surgical Products Market by Allografts Type

Chapter 8. Company Profiles

8.1 MiMedx Group. Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
8.2 Vericel Corporation
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Research & Development Expense
- 8.2.4 SWOT Analysis
8.3 Baxter International, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 SWOT Analysis
8.4 Zimmer Biomet Holdings, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Acquisition and Mergers:
- 8.4.6 SWOT Analysis
8.5 Stryker Corporation
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Acquisition and Mergers:
- 8.5.6 SWOT Analysis
8.6 Smith & Nephew PLC
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional and Segmental Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 SWOT Analysis
8.7 Arthrex, Inc.
- 8.7.1 Company Overview
- 8.7.2 SWOT Analysis
8.8 BioTissue Holdings, Inc.
- 8.8.1 Company Overview
- 8.8.2 SWOT Analysis
8.9 VSY Biotechnology GmbH
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
8.10. Aptissen S.A.
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Orthopedic Regenerative Surgical Products Market, 2019 - 2022, USD Million
TABLE 2 North America Orthopedic Regenerative Surgical Products Market, 2023 - 2030, USD Million
TABLE 3 North America Orthopedic Regenerative Surgical Products Market by End-use, 2019 - 2022, USD Million
TABLE 4 North America Orthopedic Regenerative Surgical Products Market by End-use, 2023 - 2030, USD Million
TABLE 5 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Ambulatory Surgical Centers Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Ambulatory Surgical Centers Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Orthopedic Regenerative Surgical Products Market by Application, 2019 - 2022, USD Million
TABLE 12 North America Orthopedic Regenerative Surgical Products Market by Application, 2023 - 2030, USD Million
TABLE 13 North America Joint Reconstruction Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Joint Reconstruction Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Cartilage & Tendon Repair Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Cartilage & Tendon Repair Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Trauma Repair Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Trauma Repair Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Orthopedic Pain Management Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Orthopedic Pain Management Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Orthopedic Regenerative Surgical Products Market by Product, 2019 - 2022, USD Million
TABLE 24 North America Orthopedic Regenerative Surgical Products Market by Product, 2023 - 2030, USD Million
TABLE 25 North America Viscosupplements Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Viscosupplements Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Allografts Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Allografts Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Orthopedic Regenerative Surgical Products Market by Allografts Type, 2019 - 2022, USD Million
TABLE 30 North America Orthopedic Regenerative Surgical Products Market by Allografts Type, 2023 - 2030, USD Million
TABLE 31 North America Amniotic Products Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Amniotic Products Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Synthetic Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Synthetic Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Cell-based Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Cell-based Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Orthopedic Regenerative Surgical Products Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Orthopedic Regenerative Surgical Products Market by Country, 2023 - 2030, USD Million
TABLE 41 US Orthopedic Regenerative Surgical Products Market, 2019 - 2022, USD Million
TABLE 42 US Orthopedic Regenerative Surgical Products Market, 2023 - 2030, USD Million
TABLE 43 US Orthopedic Regenerative Surgical Products Market by End-use, 2019 - 2022, USD Million
TABLE 44 US Orthopedic Regenerative Surgical Products Market by End-use, 2023 - 2030, USD Million
TABLE 45 US Orthopedic Regenerative Surgical Products Market by Application, 2019 - 2022, USD Million
TABLE 46 US Orthopedic Regenerative Surgical Products Market by Application, 2023 - 2030, USD Million
TABLE 47 US Orthopedic Regenerative Surgical Products Market by Product, 2019 - 2022, USD Million
TABLE 48 US Orthopedic Regenerative Surgical Products Market by Product, 2023 - 2030, USD Million
TABLE 49 US Orthopedic Regenerative Surgical Products Market by Allografts Type, 2019 - 2022, USD Million
TABLE 50 US Orthopedic Regenerative Surgical Products Market by Allografts Type, 2023 - 2030, USD Million
TABLE 51 Canada Orthopedic Regenerative Surgical Products Market, 2019 - 2022, USD Million
TABLE 52 Canada Orthopedic Regenerative Surgical Products Market, 2023 - 2030, USD Million
TABLE 53 Canada Orthopedic Regenerative Surgical Products Market by End-use, 2019 - 2022, USD Million
TABLE 54 Canada Orthopedic Regenerative Surgical Products Market by End-use, 2023 - 2030, USD Million
TABLE 55 Canada Orthopedic Regenerative Surgical Products Market by Application, 2019 - 2022, USD Million
TABLE 56 Canada Orthopedic Regenerative Surgical Products Market by Application, 2023 - 2030, USD Million
TABLE 57 Canada Orthopedic Regenerative Surgical Products Market by Product, 2019 - 2022, USD Million
TABLE 58 Canada Orthopedic Regenerative Surgical Products Market by Product, 2023 - 2030, USD Million
TABLE 59 Canada Orthopedic Regenerative Surgical Products Market by Allografts Type, 2019 - 2022, USD Million
TABLE 60 Canada Orthopedic Regenerative Surgical Products Market by Allografts Type, 2023 - 2030, USD Million
TABLE 61 Mexico Orthopedic Regenerative Surgical Products Market, 2019 - 2022, USD Million
TABLE 62 Mexico Orthopedic Regenerative Surgical Products Market, 2023 - 2030, USD Million
TABLE 63 Mexico Orthopedic Regenerative Surgical Products Market by End-use, 2019 - 2022, USD Million
TABLE 64 Mexico Orthopedic Regenerative Surgical Products Market by End-use, 2023 - 2030, USD Million
TABLE 65 Mexico Orthopedic Regenerative Surgical Products Market by Application, 2019 - 2022, USD Million
TABLE 66 Mexico Orthopedic Regenerative Surgical Products Market by Application, 2023 - 2030, USD Million
TABLE 67 Mexico Orthopedic Regenerative Surgical Products Market by Product, 2019 - 2022, USD Million
TABLE 68 Mexico Orthopedic Regenerative Surgical Products Market by Product, 2023 - 2030, USD Million
TABLE 69 Mexico Orthopedic Regenerative Surgical Products Market by Allografts Type, 2019 - 2022, USD Million
TABLE 70 Mexico Orthopedic Regenerative Surgical Products Market by Allografts Type, 2023 - 2030, USD Million
TABLE 71 Rest of North America Orthopedic Regenerative Surgical Products Market, 2019 - 2022, USD Million
TABLE 72 Rest of North America Orthopedic Regenerative Surgical Products Market, 2023 - 2030, USD Million
TABLE 73 Rest of North America Orthopedic Regenerative Surgical Products Market by End-use, 2019 - 2022, USD Million
TABLE 74 Rest of North America Orthopedic Regenerative Surgical Products Market by End-use, 2023 - 2030, USD Million
TABLE 75 Rest of North America Orthopedic Regenerative Surgical Products Market by Application, 2019 - 2022, USD Million
TABLE 76 Rest of North America Orthopedic Regenerative Surgical Products Market by Application, 2023 - 2030, USD Million
TABLE 77 Rest of North America Orthopedic Regenerative Surgical Products Market by Product, 2019 - 2022, USD Million
TABLE 78 Rest of North America Orthopedic Regenerative Surgical Products Market by Product, 2023 - 2030, USD Million
TABLE 79 Rest of North America Orthopedic Regenerative Surgical Products Market by Allografts Type, 2019 - 2022, USD Million
TABLE 80 Rest of North America Orthopedic Regenerative Surgical Products Market by Allografts Type, 2023 - 2030, USD Million
TABLE 81 Key Information - mimedx group inc
TABLE 82 Key Information - Vericel Corporation
TABLE 83 Key Information - Baxter International, Inc.
TABLE 84 key Information - Zimmer Biomet Holdings, Inc.
TABLE 85 Key Information - Stryker Corporation
TABLE 86 key Information - Smith & Nephew PLC
TABLE 87 Key information - Arthrex, Inc.
TABLE 88 Key Information - BioTissue Holdings, Inc.
TABLE 89 Key Information - VSY Biotechnology GmbH
TABLE 90 Key Information - Aptissen S.A.

List of Figures

FIG 1 Methodology for the research
FIG 2 North America Orthopedic Regenerative Surgical Products Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Orthopedic Regenerative Surgical Products Market
FIG 4 Porter's Five Forces Analysis - Orthopedic Regenerative Surgical Products Market
FIG 5 North America Orthopedic Regenerative Surgical Products Market share by End-use, 2022
FIG 6 North America Orthopedic Regenerative Surgical Products Market share by End-use, 2030
FIG 7 North America Orthopedic Regenerative Surgical Products Market by End-use, 2019 - 2030, USD Million
FIG 8 North America Orthopedic Regenerative Surgical Products Market share by Application, 2022
FIG 9 North America Orthopedic Regenerative Surgical Products Market share by Application, 2030
FIG 10 North America Orthopedic Regenerative Surgical Products Market by Application, 2019 - 2030, USD Million
FIG 11 North America Orthopedic Regenerative Surgical Products Market share by Product, 2022
FIG 12 North America Orthopedic Regenerative Surgical Products Market share by Product, 2030
FIG 13 North America Orthopedic Regenerative Surgical Products Market by Product, 2019 - 2030, USD Million
FIG 14 North America Orthopedic Regenerative Surgical Products Market share by Country, 2022
FIG 15 North America Orthopedic Regenerative Surgical Products Market share by Country, 2030
FIG 16 North America Orthopedic Regenerative Surgical Products Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: MiMedx Group, Inc.
FIG 18 Swot Analysis: Vericel Corporation
FIG 19 Swot Analysis: Baxter International, Inc.
FIG 20 Swot Analysis: Zimmer Biomet Holdings, Inc.
FIG 21 SWOT Analysis: Stryker Corporation
FIG 22 SWOT Analysis: Smith & Nephew PLC
FIG 23 Swot Analysis: Arthrex, Inc.
FIG 24 Swot Analysis: BioTissue Holdings, Inc.
FIG 25 Swot Analysis: VSY Biotechnology GmbH
FIG 26 Swot Analysis: Aptissen S.A.

North America Orthopedic Regenerative Surgical Products Market Size, Share & Industry Trends Analysis Report By End-Use (Hospitals, Ambulatory Surgical Centers and Others), By Application, By Product, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents